Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Short Interest Up 220.0% in October

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) saw a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 1,600 shares, an increase of 220.0% from the September 30th total of 500 shares. Based on an average daily trading volume, of 4,500 shares, the days-to-cover ratio is presently 0.4 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Stock Performance

Shares of NASDAQ:HROWM traded down $0.05 during mid-day trading on Friday, reaching $26.20. 4,897 shares of the company were exchanged, compared to its average volume of 4,125. The firm’s 50-day simple moving average is $26.54 and its 200 day simple moving average is $26.38. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 1 year low of $22.71 and a 1 year high of $27.72.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 31st. Investors of record on Tuesday, October 15th will be paid a dividend of $0.7422 per share. This represents a $2.97 annualized dividend and a yield of 11.33%. The ex-dividend date of this dividend is Tuesday, October 15th.

About Harrow Health, Inc. 11.875% Senior Notes due 2027

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.